Pregabalin 150mg (Pregabalin)

Adult dose

This medication is administered orally, divided into two doses daily, regardless of meals. Neuropathic pain (peripheral and central): Initial dose of 150 mg daily, which may be increased to 300 mg daily based on response and tolerability after 3 days to 1 week, and if necessary, may be further increased up to a maximum daily dose of 600 mg. Epilepsy: Initial dose of 150 mg daily, which may be increased to 300 mg daily after 1 week.

Child dose

Administration for children under 12 years old and adolescents aged 12 to 17 is not recommended due to insufficient safety and efficacy data.

This medication may increase the risk of suicidal thoughts or behavior, so one should monitor for mood changes or abnormal behavior while taking it. It should not be taken by individuals with hypersensitivity to the drug or with certain genetic disorders such as lactose intolerance. Diabetic patients should be cautious, as weight gain may require adjustments in diabetes control medications. If symptoms of angioedema occur, discontinue use immediately and consult a healthcare professional. Elderly patients should be particularly careful at the beginning of treatment due to the risk of dizziness or drowsiness causing falls or injuries. Blurred vision or changes in eyesight may occur, and if these symptoms appear, discontinuation of the medication should be considered. Sudden discontinuation of this medication may result in withdrawal symptoms such as insomnia, headache, and anxiety, so it should be tapered off gradually in consultation with a healthcare professional. Patients with a history of mental illness or substance abuse should be especially cautious due to the risk of drug misuse. Patients with reduced renal function may require dosage adjustments. Patients with heart disease should be aware of the risk of congestive heart failure. If taken in conjunction with opioid analgesics, side effects due to central nervous system depression may be exacerbated. Patients with impaired respiratory function or elderly individuals may require dosing adjustments due to the risk of severe respiratory depression. Pregnant women, especially in the first trimester, should consult a healthcare provider before use due to the risk of fetal malformations. Breastfeeding women should consider stopping breastfeeding or the medication, as this drug may be passed to breast milk. For activities such as driving or operating machinery, it is advisable to avoid until any dizziness or drowsiness has resolved after taking this medication. Severe skin reactions may rarely occur, so if any unusual symptoms such as rashes or swelling develop, discontinue use immediately and inform a healthcare provider. In the case of an overdose, symptoms such as drowsiness, confusion, depression, and seizures may occur, necessitating immediate medical attention, and blood dialysis may be required if necessary. This medication should be stored out of the reach of children and not transferred to other containers for safety.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in the mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory anomalies accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, vision abnormalities, paralysis, urination issues.

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is best to maintain a storage temperature between 15 and 30 degrees Celsius.

Appearance

A hard capsule with a white or light yellow powder inside, with a white cap and body.

Package unit

30 capsules/bottle, 100 capsules/bottle